References
- Jaimovich G, Lazarus HM, Gale RP. Hematopoietic cell transplants in resource-poor countries: challenges and opportunities. Expert Rev Hematol. 2023 Mar;21:1–7. Epub ahead of print. PMID: 36919565. DOI:10.1080/17474086.2023.2191946
- Ruiz-Argüelles GJ, Gómez-Rangel D, Ruiz-Delgado GJ, et al. Results of an autologous noncryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: a single-institution, 10-year experience. PMID: 14663161 Acta Haematol. 2003;1104:179–183. DOI:10.1159/000074221
- Olivares-Gazca JC, Sánchez-Bonilla D, Fernández-Gutiérrez JA, et al. Patient-reported-outcomes and safety of autologous stem cell transplantation in multiple sclerosis: a single center experience with the “Mexican method” in 1300 persons. Blood. 2022;140(Supplement 1):1178–1179. DOI:10.1182/blood-2022-163740
- Ruiz-Argüelles GJ, Seber A, Ruiz-Delgado GJ. Conducting hematopoietic stem cell transplantation in low and middle income countries. Hematology. 2022 Dec;27(1):809–812. PMID: 35894853. DOI:10.1080/16078454.2022.2105513